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ABSTRACT 
Derivatives of cyclohexanol were screened for 
pharmacological effects on intact ane~thetized rat~v 
iBolated guinea pig heart;s 9 ia \j)la.ted rat atria and iso-
lated rabbit ~ma.11 intestineo All the compounds tested 
produced a hypotensive respon~e and cardio-inhibitory effects 
varying fr~m slight depression to complete arres t o On the 
baais of recovery from induced cardiac arJrest none of the 
compounds appeared to be cardio- toxico All the compound~ 
produced inhibitory effects on the isolated small intestine 
in varying degree~o 
Methyl 3-hydroxy-2-Q.~tolylcyclohexylacetate and 
trans-3-oxo-2=.Q.-tolylcyclohexylacetic acid were equally 
potent and the most effective in their cardiovascular effect~ 
whereas the ketal from glycer~l and 2-Q.=tolylcycl~hexax;Jone 
was the most effective on the !$~lated rabbit small inte~tine. 
Studies of mechsnism 9 employing the isolated rat atria, 
indicate an antagonistic effect between these c.ompoui.nd.~ end 
calciumo 
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I. INTRODUCTION 
The production of elective cardiac arrest has become 
of interest within the past decade with the advances made in 
open-heart surgery. During cardiopulmonary by-pass procedures 
for the correction of intracardiac lesions, it sometimes is 
expedient to utilize adjuvant measures for the temporary con-
trol of cardiac per:fusion and activity. These are valuable 
assets to the cardiac surgeon and provide a quiet and dry 
field which facilitates the repair of complex cardiac defects. 
Experimental and clinical cardioplegia has been 
achieved by various techniques. 'l'hese consist chiefly of 
inducing cardiac arrest by anoxia, hypothermia, and the use 
of substance's such as acetylcholine and potassium citrate. 
Other agents and techniques have been introduced and in turn 
received with varying degrees of enthusiasm, with none of 
them reliable for routine use. The major complications are 
the difficulty in restoring the heart beat, ventricular 
fibrillation and arrhythmias, resistance to electrical 
stimulation, and myocardial damage. 
~e ideal cardioplegic agent should be able to produce 
a prompt and effective cardiac m:-rest that will continue for 
a period of time sufficient for the repair of complicated 
intracardiac pathology. It should be nontoxic to the myo-
cardium and other tissues and recovery from arrest should be 
rapid, safe and reliable (Fergulio, 1959). The synthesis of 
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new compounds that could bring about elective cardiac arrest 
has progressed at a rapid rate, but the ideal cardioplegic 
agent has 7et to be found. 
It is evident from various reports in the literature 
that several derivatives of c7olohexanol possess oardioplegio 
properties. '?he present investigation deals with the evalua-
tion of newer 07olohexanol derivatives in an effort to f'urther 
correlate molecular stl"ll.ot'Uz-e with cardio-inhibitor7 activit7. 
II • REVIEW OF THE LITERATURE 
Elective cardiac arrest, induced in the course of open 
cardiac operations with cardiopulmonary bypass, has been 
found to be a valuable technical adjunct. In particular, 
the quiet and dry field it provides greatly facilitates the 
repair of more complex anomalies. 
Since this investigation deals with the pharmaco-
logical approach to elective cardiac arrest the review of 
the literature concerns agents that produce this effect. 
'fb.e concept of temporarily abolishing cardiac activ-
ity has been known since the latter part of the nineteenth 
century. Ringer in 1883 drew attention to the effect of the 
different cations on the heart beat and Hook~r (1929) 
suggested that potassium inhibition induced by an excess of 
potassium chloride could be used to stop the heart when its 
beat was disorganized by ventricular fibrillation. He 
recommended a solution of calcium chloride as an antidote to 
potassium when re-starting the heart. This work was revived 
b;y Montgomer;y et al. (1954) in o:rder to reverse ventricular 
fibrillation in hypothermic patients. 
Senning (1952) attempted to inhibit cardiac contrac-
tions temporarily by the injection of acetylcholine, metha-
choline and potassium chloride, but he was apparently 
unsuccess!Ul because he maintained coronary perfusion which 
immediately washed out or diluted the cardioplegic agent. 
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Based on these observations, Melrose et al. (1955) 
succeeded in evolving a method of stopping and re-starting 
the heart at both normal and reduced body temperatures. 
Thirty-three adult dogs were used to determine whether the 
induction of cardiac arrest by chemical means was a prac-
tical measure. While the vital centers were protected with 
the heart-lung machine or by reduction of the general body 
temperature, cardiac arrest was induced by an injection of 
potassium citrate into the root of the aorta. The arrest 
was maintained as long as an adequate level of potassium 
citrate remained in the coronary arteries. Normal beat was 
restored when simple pertusion of the coronary circulation 
reduced the level of potassium citrate. This technique 
provided an almost bloodless operative field with excellent 
visibility. The heart is completely motionless and flaccid 
so that it can be manipulated for the exact placing of 
sutures. 
Following the work of Melrose et al. a great deal of 
interest was aroused in this field. ~aker and Dreyer (1956) 
were able to induce cardiac arrest by potassium citrate and 
demonstrated the restoration of the normal beat by simple 
per:f"usion. 
Previous experiments left unanswered the degree of 
asphyxia to be expected following cessation of coronary 
circulation during induced cardiac arrest. To investigate 
this problem, Bentall and Melrose (1957) studied the pro-
duction of lactic acid after varying periods of arrest, in 
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the isolated per!Used hearts. The lactic acid concentration 
in the effluent per.fu.sate rose af'ter interruption of per-
.fu.sion. The concentration increased progressively as the 
interruption was prolonged. 
Elective cardiac arrest with potassium citrate has been 
applied clinically by different workers employing the Melrose 
technique. Effler et al. (1956) successf'u.lly treated two of 
three cases of congenital heart disease with the heart re-
suming normal sinus rhythm in all three cases. In 1957, 
these same investigators observed that ventricular asystole 
occurred frequently with other clinical cases. 
Kolff ~ al (1957) reported that, in all of the 
thirty-seven cases in which the Melrose technique was 
applied, complete ventricular asystole was achieved and it 
was possible to restore effective heart action and adequate 
circulation. Ventricular fibrillation occurred in seven 
patients, but normal rhythm always returned. It was found 
that under the conditions of the experiment the heart could 
resume its normal action after periods of arrest as long as 
4.0 minutes. 
In a series of experiments on dogs, Helmworth and 
co-workers (1958, 1958a, 1959), found that no animals died 
following 30 minutes of total cardiopulmonary by-pass, 
whereas animals in which potassium citrate arrest was induced 
for 30 minutes had a mortality of nearly fifty per cent 
with evidence of some myocardial dam~ge. 
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At the same time other investigators were using acetyl-
choline as a cardioplegic agent. Moulder et al. (1956) re-
ported on the use of acetylcholine to inhibit cardiac 
contractions in dogs and humans under hypothermia. Lam et 
al. (1957, 1957a, 1958) reported clinical experiences with 
acetylcholine-induced cardiac arrest during intracardial 
surgical procedures. They found rapid resuscitation and low 
incidence of ventricular fibrillation during recovery. It 
was of interest to note that during acetylcholine-induced 
caiadiac arrest the heart might beat if the ventricle was 
stimulated mechanically. 
Sergeant et al. (1957) showed acetylcholine to be a 
safe and effective agent for both the hypothe:rmic and the 
normothermic dog heartso Similar success was obtained in 
eight human open-heart operations. 
Other investigators have attained less success with 
acetyleholine as a cardioplegic agent. Shramel et al. (1957) 
could produce cardiac arrest with acetylcholine and metha-
choline for only short periods of time with no complete 
cessation of electrical activity during any of the arrests. 
Kenyon et al. (1960) and McKain (1961) reported failure to 
produce cardiac arrest with acetylcholine. Bramwald et al. 
(1959) found severe depression of myocardial activity after 
20 to 30 minutes arrest with either acetyleholine -or potas-
sium citrate. 
Meanwhile, Bigelow et al. (1950, 1950a) and Swan $lid 
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Zeavin (1954) had shown that hypothermia protected the heart 
from long periods or oxygen deprivation by decreasing its 
metabolic requirements. This fact stimulated its use as a 
method for inducing cardiac arrest. Various combinations or 
chemically induced arrest in conjunction with hypothermia 
have been reported in the literatureo In a series or reports, 
Cooper et al. (1959) and Willman et alo (1959, 1959a}, have 
shown marked depression of left ventricular myocardial 
function atter a 30-minute arrest with either potassium 
citrate or acetylcholine. Partial protection or the heart 
was provided by previously cooling to 28°0. Weirich et al. 
(1959) had noted a similar effect on myocardial f'u.n.ction 
with increasing deterioration as the period or arrest wa• 
prolonged from 5 to 20 minutes. McKain (1961) and Berne 
(1958) could not maintain cardioplegia with acetylcholine 
even under hypothermic conditions. 
McFarland et al. {1960) reported myocardial necrosis 
in 79 per cent or the patients subjected to potassium cit-
rate arrest who had died at various intervals following 
open-cardiac operations. The lesion was not observed on 
the hearts or patients who underwent similar procedures 
without arrest or with ano.xic arrest. 
Kenyon et al. (1959) admini stered potassium citrate 
and acetylcholine with the in:!'usate temperature at 4° or 5°Co 
Cardiac arrest occurred in only 4 per cent or the animals 
treated with acetylcholine in comparison to 100 per cent ot 
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those injected with potassium citrateo 
An indication that, with potassium citrate arrest, 
the ATP, phosphocreatine, and glycogen levels fell much more 
rapidly than with selective cardiac hypothermia was first 
presented by Gott et al. (1959). These results have been 
cont'irmed by Hall et al. (1959) and Ellison et al. (1960)0 
According to these workers hypothermia appeared to be 
superior to arrest by potassium citrate for the maintenanae 
of the myocardial energy sources. 
Kusinoki et alo (1960), have carried out an investi-
- -
gation on cardioplegic agents in both the normothe:rmic and 
the hypothermic state. They concluded that cardiac arrest 
for fifteen minutes by eny of the techniques studied re-
sulted in depression of myocardial !'unction to 50-70 per cent 
of the control function when measured 15 minutes post-arrest. 
HY.Pothermia to 25°c partially protected the heart rendered 
hypoxic for 15 minutes; and, in comparison with other 
methods studied, cardioplegia by this technique resulted in 
least depression and best recovery of myocardial function. 
Several other chemical agents or combinations of 
these and other methods for inducing cardioplegia have been 
reported. Merrit et al. (1958) had reported that magnesium 
by itself was not a satisfactory cardioplegic agent. How-
ever, he pointed out that potassium and magnesium ions ap-
peared to act synerg!sticallyo 
Young et al. {1956) utilized a combination of magnesium 
9 
sulfate, potassium citrate and neostigmine methylsulfate to 
induce cardioplegia. The effects obtained were apparently 
superior to potassium citrate alone in terms of post-arrest 
recoveries. Similar results were obtained by Sealy et al. 
(1958) and MiJn.es et al. (1958). 
Mondini et al. (1957)s demonstrated that isolated 
guinea pig hearts were arrested in diastole for 3 to 5 
minutes with a combination of acetylcholine and procaine 
hydrochloride. 
Clark ~ al. (1959) devised a method for inducing 
cardiac arrest by passing blood through a selectively 
charged magnesium ion exchange resin. The resulting hypo-
calcemic blood was then perfused into the coronary system 
producing arrest. Recoveries a.f'ter forty-five minutes were 
obtained with no gross evidence of damage. 
Yashar et al. (1960) subjected thirty dogs to 
cardiopulmonary by-pass and cardiac arrest was achieved by 
means of various cardioplegic agents. They observed that 
cardiac arrest could be achieved with sodium citrate, sodium 
phytate, methacholine, and potassium chloride, in addition 
to potassium citrate and acetylcholine. The rate of re-
covery after cardiac arrest and perf'usion of the coronary 
arteries with arterialized blood was not predictable. There 
was no relationship between the dose injected and the dura-
tion of the cardiac arrest or the rate of recovery. None 
of the agents tested appeared safe for routine clinical use. 
·· ..  , 
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Advances in the correction of stenotic and insufficient 
aortic valves have prompted the use of a retrograde pertusion 
technique in order to facilitate the direct vision of the 
diseased valveo This technique has been employed by Gott 
~ alo (1959), Lillehei et al. (1958)j and other investiga-
torso 
In recent years it appears that hypothermia is 
favored over all other methods used to arrest the heart as 
an adjunct in open heart surgeryo 
Reports of adverse effects of prolonged elective 
cardiac arrest upon myocardial structure and .function led 
Miller et alo (1961) to undertake a comparative study of 
methods of arrest. Arrest was achieved by potassium cit-
rate, anoxia, and a combination Gf anoxia and local hypo-
thermia. The changes produced in the heart function follow-
ing arrest by potassium citrate were less than those 
observed in other groups. Extensive myocardial necrosis 
was observed following one hour of potassium citrate arrest. 
Again in 1964 9 these investigators studied the progression 
or reversibility of acute changes in myocardial .function and 
structure a.fter periods of elective cardiac arrest from 30 
to 60 minutes. 'fhey found that cardiac .function was 
variably impaired following the arrest period. Gross and 
microscopic areas of necrosis were observed in dog hearts 
following recovery from potassium citrate arrest. No 
morphological changes were observed following cardiac arrest 
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by hypothermia with or without coronary perfusion. 
Bjork and For~ (1961) performed an experimental study 
on dogs to compare the different methods of inducing cardiac 
arrest. The arrest was maintained for 30 to 40 minutes. 
Little alteration in the myocardium was found after hypo-
thermic and acetylcholine arrest whereas the moat pronounced 
changes were found after potassium. arrest . They concluded 
that deep hypothermia was preferred over the other methods 
because of the diminished oxygen demands during this type of 
arrest. 
Brewer et al. (1963) upon evaluating cardioplegics in 
patients undergoing open hes.rt surgery9 found h;rpothermic 
arrest to be superioro The mort ality following this type of 
arrest was lower than with any of the others and myocardial 
degeneration was less severe in the hearts of the patients 
that diedo 
Redo (1962) evaluated the effects of prolonged periods 
of cardioplegia on the mechanical and electrical activity or 
the isolated guinea pig heart. Arrest was achieved using 
potassium citrate 9 Sealy 1 s mixture, acetylcholine, anoxia 
and hypothermia. Arrest up to periods of 60 minutes by the 
use of potassium citrate, Sealyus mixt ure 9 or potassium 
citrate were followed by mechanical recovery of 83 to 100 
per cent. Anox.ic arrest led to the poorest return of cardiac 
action as compared with the other methods used. The results 
indicated that the l onger the d1J.11.Jt"ation or arrest, the longer 
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the heart takes to recover and the poorer is the mechanical 
recovery. Fibrillation occurred in all instances a:tter pro-
longed periods of cardioplegia except when the arrest was 
achieved by hypothermiao Fibrillation reverted to normal 
rhythm spontaneously within several minutes. 
Burdette and Al Sha.mm.a {1962) reported a decrease in 
myocardial ATP and concomitant increase in ADP and AMP 
during normothermic hypoxic or potassium citrate arrest. 
Hypothermia did not prevent the metabolic change$ but 
appeared to facilitate rec~veryo 
More recently9 Berne et al. (1964) were unable to 
show any significant differences between the potassium cit-
rate arrest and the hypothermic arrest. These findings are 
in contrast to those reported by Gott et al. (1959) 6 Hall 
et ale (1959) 9 and Ellison et al. (1960). 
From various reports in the literature it appears 
that certain structural substitutions in the cyclohexanol 
ring can bring about ca!"dioplegic properties. 
Nelson et .!!!· {1958) reported that in certain pre-
liminary experiments trans-2-.Q.-tolylcyclohexanol had been 
able to arrest the heart of a dog but recovery was not 
success.fulo 
Huitric (1959) published a note concerning the pro-
duction of reversible mechanical arrest on isolated cat 
heart with this sa:me compound. This prompted Huitric to 
synthesize a series of cyclohexa:nol derivativeso 
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Smookler and DeFeo (1962) extensively investigated 
cyclohexanol and certain of its 2-tolyl and 2-chlorophenyl 
substitution products for cardioplegic effectso The compounds 
were found to be capable of lowering the blood pressure of 
intact rats and depressing myocardial contractility of 
isolated guinea pi.g hearts o The inhibitory effects varied 
from slight depression to complete arrest. Evaluation of 
potency was based on the ability to produce cardiac arrest 
and the duration of the arresto In both series of substi-
tutions the trans-2-Q.-tolyl derivatives were the most potent 
and the cis derivatives the least potento Mechanism studies 
indicated an antagonism between these compounds and calcium. 
In unpublished work 9 Smookler (1961) showed that 
trans-2-.Q.-tolylcyclohexanol 9 tran~-2-Q-chlorophenylcyclo­
hexanol and cyclohexanol were capable of inducing cardiac 
arrest in dogs undergoing cardi~pulmonary by-pas~o There 
appeared to be no relatio~hip between the dose employed 
and the production of cardiac arresto Recovery was faster 
and more consistent with trans-2-Q-tolylcyclohexanol. 
Unpublished work by Smith (1963) showed that other 
derivatives of cyclohexanol produced similar effects in the 
cardiovascular systemo The compounds teated were trans-2-.Q.-
tolyl, cis-2-.Q.-tolyl9 tranai-2-Q-t ·Dilyl 9 and cis-2-Q-tolyl 
derivatives of cyclohexylamine hydrochloride and other mis-
cellaneous cyclohexane derivatives. Trans-2-o-tolylcyclo-
hexylamine hydrochloride was the moat potent of the cyclo-
hexylamine series testeda 
~ 
Other derivatives of cyclohexanol and cyclohexylamine 
were evaluated similarlyo Unpublished work by Kosegarten 
(1966) showed that the non-ethy.nyl cyclohexanol derivatives 
were more potent in producing a hypotensive response than 
were the derivatives of cyclohexylaminea Trans-2-Q.-tolyl-
£.!!. - 1 9 4-cyclohexanediol and trmJJ.~-2~Q.-tolyl-tran~-lD5-
cyclohexanediol were equally effective and the most active. 
Converselyj the cyclohexylamines were more potent cardio-
plegic agentso An antagonistic effect between calcium and 
the negative inotropic action of these compounds was demon-
strated on isolated rat atria. 
Based on these reportsj there appears to be justi-
fication in assessing the comparative cardioplegic effects 
of other cyclohexanol derivativeso 
III. ~ INVESTIGATION 
!• Objectives 
It is evident from recent reports in the literature 
that certain substituted cyclohexanols show cardioplegie 
prctperties. Smookler and DeFeo (1962) repol'tad that certain 
cyclohex1µ1ol derivatives in a series synthesized by 
Huit~ic were also capable of producing cardiac arrest. 
Similar results were obtained by Smith (1963) with substi-
tru.ted cyclohex7laminea and miscellaneous cyclohexan.Bl 
derivatives. Since that time Huitric has synthesized another 
group of cyclohexanol derivatives. 
This investigation was undertaken to determine the 
comparative effects of these substitution products on the 
cardiGvascular system and to attempt to relate the various 
ef.f'&cts of the compounds to their molecular stl"tlctures. 
The objectives of the investigation were as follows: 
1. ~o screen pharmacologically the various compounds 
.for their e.f'f'ecta on the animals or tissues used. 
2. To attempt to determine the mechanism through 
which the compounds' effects are brought about. 
~. !he Cpmpounds 
The substituted cyclohexanols used in this investiga-
tion (Figure 1) were synthesized by Dr. Alain C. Huitric of 
the Department of Pharmaceutical Chemistry, University of 
Washington, College of Pharmacy, Seattle, Washington. Since 
-CH J-0-CH 
2 ' 
H 
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Figure lo Cyclohexanol Derivatives 
-OH 
-OH 
>=O 
rl_b 
~\fS/ 
R2 
Nmne 
methyl 3-hydroxy-2-.Q.-tolyl-
c yclohexylac etate 
(SH-24) 
methyl 3-acetoxy-2-.Q.-
tolylcyclohexylacetate (SH-26) 
3-hydroxy-2-.Q.-tolyloyclo-
hexylacetic acid 
(SH-23) 
trans-3-oxo-2-.Q..-tolylcyclo-
hexylacetic acid (SH-16) 
0 )< ............._ keta.l or glycerel and 2-o-0-CH~H-CHzOH tolylc yclohexanone -
~ (#5) 
CH I 3 
2-.Q..-tolylcyclohexen-2-one 
( SH-ll~_) 
the solubility of the compounds was not reported by Dr. 
Huitric, the water solubilities were determined according 
to the ~ollowing procedure: 
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Ten to 25 mg of the compound was weighed into a vial 
on a Mettler analytical balance. Deionized water was added 
dropwise from a pipette. After each addition the vial was 
thoroughly agitated. It was found necessary in all oases 
to employ heat to effect the solution. The procedure was 
repeated three times for each compound, and the average of 
the three determinations was taken as the solubility. Once 
the compound had dissolved, it remained in sol~tion for at 
least several hours. 
Some of the compounds were practically insoluble in 
water. The water solubilities of these compounds. were not 
determined. They were dissolved in a mixture of polyethylene 
glycol (400) and water. Table I lists the physical state of 
the compounds and the water solubilities. 
C. Animals Used 
Rats--Albino rats of the Wistar (MW-2) strain were 
employed for all the rat experiments. 
Guinea pigs--The guinea pigs used were of a hetero-
geneous group. 
Rabbits--All rabbits were albino. 
D. Experimental Procedures and Results 
This investigation was divided into four sections: 
1. The effects of the compounds on the blood pressure of 
intact anesthetized rats. 
2. The effects of the compo'Ull.ds on isolated guinea pig 
hearts. 
3. The effects of the compounds on isolated rat atria. 
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4. ~he effects of the compounds on rabbit intestinal smooth 
muscle. 
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TABLE I 
Physical state and water solubility of various 
derivatives of cyclohexanol. 
Compound 
methyl 3-hydroxy-2-.Q_-tolyl-
c yclohexylacetate 
(SH'-24) 
trans-3-oxo-2-.Q_-tolylcyclo-
hexylacetic acid (SH-16) 
3-hydroxy-2-.Q..-tolylcyclo-
hexylacetic acid 
(SH-23) 
methyl 3-acetoxy-2-.Q..-tolyl-
cyclohexylacetate 
(SH-26) 
2-.Q_-tol1lcyclohexen- 2-one 
(SH-14) 
ketal of glycerol and 2-o-
tolylcyclohexan.one 
Physical 
State 
solid 
solid 
solid 
solid 
solid 
liquid 
Water 
Solubility 
(mg /ml.) 
6.3 
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1. Effects of Various Derivatives of Cyclohexanol .Q.B the 
Blood PI"el!sure of Ra.ts 
A· Experimental Procedures 
Wister rats of either sex weighing approximately 
200 g were anesthetized by an intraperitoneal injection 
of l.2g/kg of u:rethan and ~ecured to an animal board, 
ventral side upo A midline incision was made into the 
neck, and the trachea was ca.nnulated to in~ure freedom of 
respirationo The right carotid artery was isolated and 
eannulated with a fine glass cannula connected to a U-tube 
mercury manometer via polyethylene and rubber tubingo 
The entire system was filled with normal saline 
(0.9~ NaCl) an.d the pressure in the system was increased to 
approximately 90 mm Hg to prevent undue loss of the animal~s 
blood into the saline bridgeo To prevent clotting a solution 
of Ool ml of heparin sodium was added to the cannula prior 
to cannulati~no The blood pressure was recorded by means 
of a glass capillar~ float from the manometer onto the smoked 
paper of a slowly moving kymograph. The time was recorded 
simultaneou~ly with the blood pressure. The blood pressure 
was allowed t o s t abilize for a period of 30 minutes prior 
to administration of any of the experimental compounds. 
The compounds were adll'.l.inistered intravenously in either 
femoral veino The various injections were carried out at 
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intel'"Val.s which allowed ret'\lU>n ef the blood praasuPe to a 
stead7 ~tate lev~lo The t~t91 number of injecti~ns did not 
exceed four per e.xperiment" Dt')sage was adjusted acco:t'ding 
to the results obtainedo In o~der to detel'mine the dose ~t 
a particular c~mp~und that would produce a drop in bl~od 
pres&lU"'e or approximat~ly 50 pe~ cent 9 the do~e used and 
the response obtained were $Ubjec~ed to linear regre~sion 
computation~ earl"i.ad out b7 the IBM 1410 computero 
In the~e e.xpel"iment~ ~nly methyl 3-hydroxy-2-_2.=tolyl-
c7clohexylacetate and tran~-J~oxo-2-.2,-tolycyclohexylacetic 
acid were te~ted 9 5ince the othe~ compounds were, tor all 
practical pu:rpose~g insoluble in water and the solvent 
employed for their admini~tration interfered with their 
response o 
The activity of' the <H.~mpoim.dB was evaluated a~ 
t'ollows: 
lo The pe~ cent change from the norimal b1ood pre~su~e p~~~ 
duced by the compotm.d~o 
2.. !he dltil"'atitm. oif' the h;rptl!t~:wiive et.feet. 
). 2.'he dose of the compound~ needed to p~oduce a 50 p~l" cent 
cb>~p in blo~d p~e~~lU'~. 
b., Result~ 
'!he re~ult~ include the f'ollow:ing8 
lo Effect~ of the comp©und~ ~n the blood preS$Ure of rats 
(Table~ II an.d III). 
2o A co:mpa:f'i~on of' the compound~ tested on the blood p:re5~Ul"e 
o:r rats (if able IV and Figwt"ei 2) .. 
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TJtBLE II 
E.ffect:s of methyl 3-·hyd:rr•c:K:y-2-.Q.~tolylcyclohe.xyla.cei·tililt'!f 
(SH-24.) on the blood pressure of rat2u 
Dose 
'(mg/Kg} 
2 
4 
8 
12 
16 
18 
N U.."llb e: r 
of 
Trial~ 
4 
3 
4 
3 
4 
3 
Mean '/, Droop 
in Blood 
PI"s~~rure 
't S oDo 
Dura.ti.on o.t" Drop 
in Blood Pz·a~~ure 
(Mean and Range) 
(aec) 
41 (J0-50) 
42.3 (250=600) 
1020 (900-1140) 
1195 (1000-1!.i.J..i.o) 
920 (860=1000 ) 
·---------
---
TABLE III 
Ef'fec~t~ ot' tJr"an~-3=oxo~2-Q.-ttlllylcyclohexylacetlc ~ldd 
(SH-lbJon the bltir,id pressure of' rai;~o 
Do~e 
(mg/Kg) 
4 
8 
10 
12 
15 
18 
Number 
of· 
Trial~ 
4 
2 
3 
Ji 
,,., 
:;i 
2 
Mean% Drop 
in Blood 
Pressure 
°!' ~LD o 
17 ± 6 
36 + Oo7 
-
40 + 4oO 
-
48 t 9o0 
5E5 + 800 
-
78 + 2.0 
-
DuX<>a:t.i on o:f.' D;;r:•op 
i.n BlfJod F1"9~1:rtU'"e 
(Me an and Raz.i.ge1 ) 
( ~e(;;) 
187 {100-.300) 
·---- ·-------- . ~~-~--
TABLE IV 
A comparison o.f the ED50 (hypotensive) of the cyclohexanol 
derivatives tested on the blood pressure 8 • 
Compou..nd 
methyl 3-hydroxy-2-..Q.~ 
tolylc;yclohexylacetate 
(SH-24) 
trans-3-oxo-2-~-tolyl­
cyclohexylacetic acid (SH-16) 
asee Figure 2. 
•rota.l 
Trials 
21 
17 
Calculated ED50b 
mg/kg 
11~2 
11.0 
hnerived f'rom the regression line f ormula ob"tained 
.from the analysis of' results on the IBM 1410 Computer~ 
0 
-20 
CJ 
1. 
~ 
i:s 
co 
0) 
~ 
~ 
11. 
~40 
'O 
0 
0 
Ii:! 
~ 
·~ 
«>60 <J 
~ 
-80 
1.3 
Figure 2. 
~ .. ~ ... 
1.6 109 2.2 
Lag of Dose (mg/Kg x 10) 2.5 
A comparison of the blood pressure effects produced by the 
@yclo~xanol derivatives tested. 
2. The Effects of Various Cyclohexanol Derivatives .2!!. the 
Isolated Guinea Pig Heart 
A• Experimental Procedures 
Guinea pigs of either sex were sacrificed by cervical 
dislocation. '!'he thoracic cavity was opened and the aorta 
was clamped. The heart was removed and transferred to a 
container of oxygenated per.fusion solution. The aorta 
was immediately ca:nnulated via an incision made in the 
ventral surface. A few milliliters of warm perfusion 
solution was forced into the cannula to remove residual 
blood from the coronary vessels and to determine whether 
the tip of the cannula was occluding the coronary vessels. 
The excised cannulated heart was quickly suspended 
in an Anderson-Craver Apparatusl for the continuous per.fusion 
of the heart. Chenoweth 1 s solution (1946) as modified by 
Smookler and DeFeo (1962) was used as the perfusion fluid. 
The composition of the perfusion solution expressed in grams 
per liter is as follows: 
sodium chloride 
potassium chloride 
calcium chloride 
magnesium sulfate 
dextrose 
sodium bicarbonate 
g/l 
7.00 
0.42 
0.24 
0.52 
1.80 
2.10 
1Metro Industries, Long Island City, New York. 
Three liters of stock solution containing 350 g sodium 
chloride, 21 g potassium chloride, 12 g calcium chloride, 
and 26 g magnesium sulfate were prepared and stored at 
room temperature. The final perfusion solution was pre-
pared the day of the experiment by taking 120 ml of the 
stock solution, 3.6 g of dextrose, and 4.2 g of sodium 
bicarbonate and diluting to 2 1 of solutiono 
A mixture of oxygen (95%) and carbon dioxide (5~) 
was bubbled continuously through the solution in the 
reservoir bottle. A constant temperature of 37o5°c was 
maintained throughout the experiment. The effluent fluid 
was recirculated during the experiment, except after the 
injection of the drug when at least 40 ml was withdrawn 
to insure complete removal of the drugo 
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After the preparation had equilibrated, any remain-
ing extraneous tissue was removed and a stainless steel 
hook was inserted through the apex of the heart. The 
amplitude of contractions of the heart was recorded on a 
standard kymograph by passing a thread from the hook to the 
recording lever via a pulley system. 
Injections were made via an injection spiral connected 
to the perfusion canal. Since the calculated volume of the 
spiral was 1.5 ml, this same amount of the perfusion solu-
tion was injected in the same manner after each injection, 
to insure complete administration of the drug. 
The number of injections performed in each preparation 
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depended on the ability of the heart to recover from a pre-
vious dose and was always limited to five trialso Only one 
compound was tested in each experiment. A depression of 
95 per cent or more was considered to be cardiac arrest. 
When testing the compounds soluble in a mixture of 
polyethylene glycol and water, an equivalent amount of the 
solvent was employed as a control, prior to each injection, 
in order to determine its effects. 
The dose and response were subjected to linear re-
gression computations carried out by the IBM 1410 computer. 
The dose producing 50 per cent negative inotropic response 
was calculated from a graph. 
The activity of the compounds was evaluated as 
f'ollows: 
1. The incidence of cardiac arrest at a particular 
dose, and the duration of arrest at that dose. 
2. The incidence and per cent of cardiac depression, 
it no arrest occurred. 
3. The time to return to 50 per cent of the normal 
contractions. 
b. Results 
The results include the following: 
1. i'b.e effects of the various cyclohexanol derivatives on 
the isolated guinea pig hearts (Tables V to X). 
2. A comparison of the effects of the various compounds on 
the isolated guinea pig hearts (Table XI and Figure 3). 
Dose 
(mg) 
o.s 
1.0 
1.5 
2.0 
Cardiac 
TABLE V 
Effects of methyl 3-hydroxy-2-o-tolylcyclohexylacetate 
(SH-24) on the isolated guinea pig hearto 
Arrest Duration of Mean 3 Depression Time of 503 
Arrest/Trial Arrest + 
-
S.D. Return 
(sec) (if no arrest) Mean and Range 
(sec) 
0/3 34 + 2 55 (50-60) 
0/3 57 + 1 85 (80-94) 
0/3 78 + 12 126 (100-150) 
-
2/3 200 (120-280) 89 + 5 297 (180-430) 
Dose 
(mg) 
OoS 
0.75 
loO 
2o0 
2o5 
TABLE VI 
Effects of trans-3-oxo-2~o-tolylcyclohexylaeetic acid 
(SH=l6) on th~ isolated guinea pig hearto 
Cardiac Arrest 
Arrest/Trial 
0/2 
0/2 
0/2 
0/3 
2/2 
Duration of 
Arrest 
(sec) 
78 (70=85) 
Mean 3 Depression 
(if no arr~st) 
!" So Do 
18 + 2 
38 + 4 ~ 
53 + 4 
82 + 7 
-
Time of 503 
Return 
(Mean and range) 
(sec) 
100 (80=120) 
130 (110=150) 
490 (480-500) 
217 (190=250) 
220 (200=240) 
Dose 
(mg) 
0.10 
0.25 
TABLE VII 
Effects of methyl 3-acetoxy-2-o=tolyleyclohexylac~tate 
(SH-26) on the isolated~guinea pig heart. 
Cardiac Arrest 
Arrest/Trial 
0/2 
0/2 
1/4 
2/2 
Duration of 
ArreBt 
(sec) 
150 
125 (120-130) 
Mean 3 Depression 
+ "'D 
=- L)C)o I) 
(sec) 
(if no arrest) 
35 ~ 4 
39 ~ 5 
85 .! 8 
Time of 503 
Return 
(Mean and range) 
(sec) 
110 (100-120) 
170 (15000 190) 
427 (320~500) 
285 (270-300) 
Dos~ (mg} 
TABLE VIII 
Effe©ts of 2-o~tolylcyclohexen=2=one (SH=l4) 
on the I'solated guinea pig heart~ 
Cal'diac Arr~st 
Al' rest/Trial 
0/3 
0/3 
0/3 
2/4 
Duration of 
Arr~st 
(sec) 
(Mea~ and range) 
137 (130=145) 
Mean 3 Depr@ssion ( if no arr@s t ) 
= SoDo 
26 + 3 
= 
28 .t 3 
57 + 2 = 
92 + 6 ~ 
Tim~ of 503 
R.etu:t>n 
(Mean and range ) 
(s~(l) 
87 (70-110) 
92 (80=105 ) 
133 (125-150) 
212 (150-320) 
Dose 
(mg) 
2.S 
s.o 
6.0 
7. () 
8.0 
·TABLE IX 
Effects of l-hydroxy-2-o-tolylcyclohexylacetic acid (SH-23) 
on the isolated guinea pig heart. 
Cardiao Arrest 
Arrest/Trial 
0/2 
0/2 
0/2 
0/2 
0/2 
Duration of Mean 3 Depression 
Arrest (if no arrest) 
(Mean and range) !' s. D. 
10 + 7 
12 + 8 
-
8 + 
-
3 
23 + 11 
-
30 + 13 
-
Time of 501 
Return 
(Maan and. range) 
9 (7-11) 
9 (6-12) 
12 (11-13) 
18 (16-20) 
24 (21-27) 
Dos® 
(mg) 
TABLE X 
Effects of ketal of glycerQll and 2=o=tolylcyiclohexanone 
on the isolated guinea pig heart. 
Cardiac Arrest 
Arrest/Trial 
0/3 
0/2 
1/3 
3/3 
Duration of 
Arrest 
(sec) 
(Mean and range) 
65 
73 (40-100) 
Mean 3 Depression 
!: S.D. 
(if no arrest) 
29 + 7 
57 + 3 
78 ! 3 
Time of 503 
Return 
(M~an and range) 
(sec) 
77 (46=104) 
105 (90-120) 
305 (180=330) 
110 (100-120) 
TABLE XI 
A comparison of the ED95 (cardio-inhibitory) of the 
cyclohexanol derivatives on the isolated 
guinea pig hearta. 
Compound 
methyl 3-hydroxy-2-2-tolyl-
cyclohexylacetate (SH- 24) 
trans-J-oxo-2-.Q.-tolylcyclo-:, 
hexylacetic acid (SH-16) , -~ 
2-o-to~1lcyclohexen-2-one 
TsH-14) 
·-
methyl 3-acetoxy-2-.Q_-tolyl-
cyclohexylacetate (SH-26) 
ketal of glycerol and 
2-..2_-tolylcyclohexanone 
3-hydroxy-2-Q_-tolylcyclohexyl-
acetic acid (SH-23) 
asee Figure 3. 
Total 
Trials 
12 
11 
13 
10 
11 
10 
2.11 
3.89 
4.17 
5.52 
c 
35 
bnerived from the regression line formula which was 
obtai.ned from the analysis of results on the IBM 1410 Computer. 
c Compound did not produce more than 30 per cent depres-
sion in the dosage range tested. 
-0 
=20 ~ 0 
·If~ 
# 
g 
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<l 
~ 71 
ti ' 
~80 5 
=100~. ~~~~~~-'--~~~~~~-.-~~~~~~~~~~~~~-.--~~~ 
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L©g of Dose (mg X 10) 
Figuir® 3 . A ©ompal'i~(tln of t~ ©al'dii&»~inhibit@ry effeints proouicEid by 
th~ various ©~l©h®xanol d~rivatives tested. 
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.1· ~ E.ff'ecta of' Various Cyclohexanol Derivatives fill.~ 
Isolated Rat Atria 
a. Experimental Procedure 
Albino rats, either male or female, were sacrificed 
by cervical dislocation. The thoracic cavity was opened by 
removal of the sternum and the heart was rapidly removed 
and immersed in a container filled with warm oxygenated 
solution. After 20 to 30 minutes the atria were freed of 
ventricular muscle, fat, and connective tissue and suspended 
in a tissue bath containing the same nutrient solution as 
used in the per.fusion experiments. 
The temperature of the bath was maintained at 32°c 
as suggested by Webb (1950) in order to reduce the rate and 
increase the amplitude or contractions. The solution in 
the bath was continuously aerated with a mixture of oxygen 
(95%) and carbon dioxide (5%). 
The tip of the right atrium was then attached to a 
stainless steel hook attached to a recording lever with a 
thread. A second hook attached to a removable glass oxygen 
bubbler in the organ bath was then inserted to the left 
atrial appendage. The lever was adjusted for maximum 
magnification of contractions. The amplitude of contractions 
and the rate of spontaneous contractions were recorded on a 
slowly moving kymograph. In order to obtain a constant 
amplitude of contraction the atrial preparation was kept in 
the bath .for at least 30 minutes before starting the experiment. 
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Methyl 3-acetoxy-2-.Q..-tolylcyclohexylacetate was selected for 
mechanism studies on the isolated rat atria. A 4 per cent 
solution of calcium chloride was used to determine the 
possible interactions with the compound. All compounds 
were allowed to act for 3 minutes before washing or adding 
other agents. 
The activity of the compounds was evaluated as 
follows: 
1. The per cent change in the amplitude of con-
t .raction. 
2. The· change in the rate of the preparation. 
b. Results 
The results include the followingi 
1. The effects of the various cyclohexanol derivatives on 
the isolated rat atria (Tables XII to XVI). 
2. A comparison of the effects of the variou.s compounds on 
the isolated rat atria (Table XVII and Figure 4). 
J. Calcium chloride (4.0 mg) produced an increase in the 
amplitude of contraction of approximately 80 per cent 
at the end of 3 minutes. Over the period of 3 
minutes, the rate of contraction increased. 
4. A dose of 0.75 mg of the compound reduced the amplitude 
of contraction by approximately 50 per cent within 1 
minute, with no apparent change in rate. 
5. When methyl 3-aoetoxr-2-.Q.-tolylcyclohexylacetate had 
reduced the amplitude ot contraction by 50 per oent 
it was round that it required 4 successive doses or 
4.0 mg ot calcium chloride each to restore the 
amplitude ot contraction to a normal levelo When 
39 
16 mg was administered at one time there was complete 
rec.ovary within 3 mi.nutes. 
Dose 
(mg) 
1.0 
1.5 
2.0 
3.0 
4.0 
TABLE XII 
Effects of' methyl 3-hydroxy-2-.Q.-tolylcyclohexylacetate (SH-24) on the isolated rat atriao 
Number 'fo Change in 
'fo Depression Rate 
of ± S.,D. (Mean & Range) Trials 
3 25 + 8 7 (4-10) 
3 31 ± 2 5 (1-11) 
3 56 + 12 7 (4-10) 
-
3 31 + 6 8 (6-10) 
-
3 46 + 
-
9 12 (5-22) 
Dose 
(mg) 
Oo25 
Oa50 
0.75 
1.00 
2o00 
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TABLE XIII 
Effects of methyl 3-acetoxy-2-.Q.-tolylcyclohexyl 
acetate (SH-26) on the isolated rat atria. 
Number 
of' 
Trials 
3 
2 
2 
3 
3 
'/o Depression 
:! S.D. 
15 ! 2 
31 ! 11 
51 ! 11 
55 '! 5 
44 '!" 11 
fo Change in 
rate 
(Mean & Range) 
11 (9-14) 
13 (12-14) 
8 (4-11) 
26 (23-29) 
13 (10-15) 
Dose 
(mg) 
1.0 
1.5 
3.0 
4.5 
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TABLE XIV 
Efrects of 2-Q.-tolylcyclohexen-2-one (SH-14) 
on the isolated rat atriaa 
Number 
o:r 
Trials 
3 
3 
5 
2 
% Depression 
± S .. D. 
25 + 15 
-
34 '!' 8 
46 "!' 6 
72 + 2 
% Change in 
rate 
(Mean & Range) 
6 (3-10) 
15 (7-22) 
22 (19-24) 
37 (33-41) 
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Effect$ ~f the ketal of glycerol and 2~.Q.-tolylcyclohexanone (#5) on the isolated rat atriao 
0.73 
1.45 
2.92 
5.80 
N'tlmber 
of' 
T:t11ial~ 
3 
3 
2 
% Depres$ion 
'!' SoDo 
23 '!' 13 
49 ~ 6 
69 ~ l 
75.3 '!' 1 
Change in Rate 
(Mean an~ Range) 
13 ( 9-16) 
Do~e 
{mg) 
TABLE XVI 
Effects of tr~a-3-oxo-2-Q- tolylcycl~hexylacetic 
acid {SH=i6) on the i~~lated rat atriao 
Nuimber 
or 
Trials 
3 
2 
2 
35 "!' 1 
% Chmge 
in Rate 
5 (2-8) 
7 ( 0-7> 
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TABLE XVII 
A comparison of the ED~0 of the c7clohexanol derivatives ~ested on the 
isolated rat atriaoa 
Compc~d 
met~11 3-h7drox7-2-.2_-tol7l-
oyolohex7lacetate (SH-24) 
meth7l J-acetox7-2-a.-
tol7l0Jolohex7lacetate (SH-26 
ketal of gl7cerol and 
2-.e,-tolyloyolohexanone 
2-o-tot!lc7olohexen-2-one TSR- . ) 
•see Figure 4. 
NW11ber 
ot 
Trials 
15 
14 
11 
5o85 
1.38 
lo75 
2.56 
45 
'bnerived t:rrom the regrea1d.cn line .tormu.la obtained 
from the anal7sis of the re1nlllts on the IBM 1410 Computero 
0 
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Log of Dose (mg x 10) .8 
Figure 4. A comparison of the effects produced by the various cyclohexanol deriva-
tives tested on the isolated rat atria. 
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l!· ~Effects ot Various C:Yclohexanol Derivatives .Q.B the 
Isolated Rabbit Ileum 
Ja• Experimental Procedures 
In order to determine the effects on smooth muscle 
some of' the compounds were tested on rabbit small intestine, 
utilizing the Magnus batho Rabbits of either sex were 
deprived of food for a period of 24 hours prior to the 
experimento The animals were sacrificed by cervical dis-
location. The small intestine was then removed from the 
body and washed with warm Tyrode's solution to remove all 
fecal matter. A small strip of the tissue (ileum), about 
2 cm long, was suspended in a 70 ml Magnus bath contain-
ing Tyrode's solution. 
A mixture of 95% oxygen and 5% carbon dioxide was 
continuously bubbled through the solution in the batho 
The temperature of the solution was maintained at 38°c by 
means of a constant temperature unit. 
The spontaneous contractions of the ileum were re-
corded on a slowly moving kymograph drum. After placing 
the segment of ileum in the bath a period of about one half 
hour was allowed before e:n.y drugs were injected. These were 
added directly to the muscle chamber with a syringe. A 
fresh piece of ile"Wl'l was employed for each drugo The mixing 
of the drugs in the bath was facilitated by the bubbles of 
gas by which the bath was oxygenatedo Following each dose, 
fresh solution was added to the batho If the tissue 
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recovered sufficiently~ it was used for three trials before 
replacing with a new stripo 
'l'he response of the preparation wa.s measured aa 
follows: 
1. The change in the amplitude of contraction of 
the ti~sue. 
2o The change in the rate o:f contraction of the 
preparationo 
3o The change in the tone of the tissuee 
b. Results 
The results include the followingi 
1. The effects of various cyclohexanol derivatives on the 
isolated rabbit ileum (Tables XVIII to XXII)o 
2o A dose of Oo70 mcg of acetylcholine established sub-
maxima.1 contractions of the intestinal strip within 30 
seconds. When the ketal of glycerol and 2-o-tolylcyclo-
hexanone had reduced the amplitude of the inte~tinal 
strip by approximately 50% at the end of 3 minutes, 
it was found that the compound did not antagonize the 
action of acetylcholineo 
Dose 
(mg) 
1.00 
1.48 
2.00 
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TABLE XVIII 
Effects of methyl 3-hydroxy-2-.Q.-tolylcyclohexyl-
aoetate (SH-24) on the isolated rabbit ileumo 
~ Change in 
Amplitude& 
13 
8 
18 
20 
26 
41 
~ Change 
in Rate'a 
7 
7 
14 
7 
0 
7 
'/, Change 
in Tone.a 
0 
0 
0 
0 
0 
0 
&All values represent a decrease from normal values 
expressed as 100 per cent. 
....... 
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TABLE XIX 
Effects of meth7l 3-acetoxy-2-.Q.-tolylcyclohexylacetate 
(SH-26) on the isolated rabbit ileum. 
Dose 
(mg) 
0.30 
0.50 
0.87 
1.74 
'I> Ohange in 
Amplitudea 
0 
9 
8 
4 
17 
.32 
22 
51 
'{. Change 
in Ratea 
0 
0 
0 
0 
0 
0 
0 
0 
'{. Change 
in Tone• 
8 
12 
11 
9 
3 
16 
16 
20 
aAll values represent a decrease from normal values 
expressed as 100 per cent. 
Dose 
(mg) 
2.0 
3.0 
4.0 
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TABLE XX 
Effects of 3-hydroxy-2-.Q.-tolylcyclohexylacetic 
acid (SH-23) on the isolated rabbit ileum. 
'/, Change in 
Amplitudea 
+ 9 
0 
+10 
+10 
+ 4 
+4 
'/, Change 
in Ratea 
+12 
0 
0 
0 
+ 7 
0 
~ Change 
in Tonea 
-3 
-3 
-7 
-6 
-1 
-3 
aValues represent an increase (+} or decrease (-) as 
compared to normal values expressed as 100 per cent. 
.Dose 
(mg) 
3.0 
6.0 
9.0 
TABLE XXI 
Effects of 2-Q.-tolylcyclohexen-2-one (SH-14) 
on the isolated rabbit ileumo 
'!> Change in 
Amplitudea 
9 
15 
13 
16 
30 
~Change 
in Ratea 
0 
6 
0 
7 
6 
52 
"' Change in Tonea 
70 
48 
22 
45 
47 
aAll values represent a decrease from normal values 
expressed as 100 per cento 
.. 
Dose 
(mg) 
0.48 
o.89 
1.78 
2.24 
2.68 
2.90 
53 
TABLE XXII 
Effects of the ketal of glycerol end 2-.Q.-tolylcyclo-
hexanone on the isolated rabbit ileum • 
. ~ Change in 
Amplitudea 
17.8 
18.1 
38.4 
25.0 
27.2 
32.0 
68.0 
74.0 
71.0 
74.0 
77.0 
77.0 
82.0 
100.0 
~Change 
in Ratea 
1.8 
o.o 
7.0 
o.o 
6.o 
o.o 
Q.0 
17.0 
J.4.o 
o.o 
o.o 
o.o 
o.o 
fo Change 
in Tonaa 
6.4 
4.0 
12.5 
10.0 
o.o 
o.o 
10.0 
13.0 
8.o 
7.0 
1).0 
2.0 
2.0 
100.0 
aAll values represent a decrease from normal values 
expressed as 100 per cent. 
IVo DISCUSSION 
Previous reports in the literature have indicated 
that several cyclohexanol derivatives can produce a hypo-
tensive effect and possess cardio-inhibitory properties. 
A preliminary investigation by Huitric et a~. (1959) 
demonstrated that an intravenous injection of trans-2-,2.-
tolylcyclohexanol Rroduced a rapid hypotensive effect on 
the intact dog. A r~versible cardiac arrest was produced 
~ 
without affecting myocard~al properties when this compound 
was perfused through isolated cat hearts. Pharmacological 
evaluation studies by Smopkler and DeFeo (1962), Smith 
(1963), and more recently by Kosegarten (1966) showed the 
degree of cardio-inhibitory activity to be related to the 
f'unctional groups and stereochemistry of these compoundso 
In this investigation, a number of substituted cyclohexanol 
compounds, synthesized by Huitric, were investigated for 
their effects on the cardiovascular system in an effort to 
~ther determine their possible C&.r'dio-inhibitory activity 
as related to moleculal" structure. 
To determine the gross effects produced by these 
compounds on the ca:rdiovascular system, studies were under-
taken utilizing the blood pressure of rats. Only two of the 
compounds could be tested for hypotensive activityo The 
other compounds were not soluble in water and the solvent 
system employed for these derivatives was found to possess 
an effect of its own. ~he compounds investigated were: 
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methyl 3-hydroxy-2-.Q.-tolylcyclohexylacetate and trans-J~oxo-
2-.Q.-tolylcyclohexylacetic acid. The results demonstrate 
that both compounds produce a rapid hypotensive activity upon 
intravenous injection. The duration of' action varied from a 
few minutes to over 30 minutes. The magnitude of the effect 
appears to be somewhat proportional to the dose employed for 
each compound. It was observed that these compounds usually 
produced some degree of' respiratory depression which paral-
leled the hypotensive response. These findings confirm 
those previously described by Smookler and DeFeo (1962), 
Smith (1963), and Kosegarten (1966). 
The comparison of the ED50 (hypotensive) indicates 
that methyl 3-hydroxy-2-.Q_-tolylcyolohexylacetate (SH-24) and 
trans-3-oxo-2-.Q.-tolylcyclohexylacetic acid (SH-16) were of 
approximately equal potency. The actual ED50 dose values 
of these compounds dif'fered by only 0.20 mg with the former 
exerting a slightly greater effect (Table IV). Smookler ad 
DeFeo have reported that substitution of a tolyl or chloro-
phenyl moiety in the number two position of the cyclohexanol 
ring increases its hypotensive activity from 6 to 40 times. 
It is evident that the f'ree acid (SH-16) and the methyl 
ester (SH-24) show little difference in activity. This 
slight dif'ference could be attributed to the free movement 
of the hydroxy group in the number 3 position in compound 
SH-24 in comparison to the restriction on SH-16 due to the 
presence of a double bond. Because of the non-availability 
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of the cis and trans isomers of the first compound and the 
els isomer of the second compound 9 no correlation could be 
made between spatial configuration and hypotensive effect. 
All the compounds ware tested for their effects on 
iaolated guinea pig heartso Control injectio~ using the 
solvent system employed for s~me of the compounds (Poly-
ethylene glycol) ~howed the solvent to produce a transient 
positive inotropic effecto From Tables V to Xj it can be 
seen that 9 at t~e dose levels employed on the isolated 
guinea pig heart~ 9 all the compounds tested depressed the 
amplitude of cont~actiona of the isolated hearts and produced 
complete arrest 9 with the exception of 3-hydroxy-2-.Q.-tolyl-
cyclohexylacetic acido With this compound only a 30 per cant 
decrease in the amplitude of contractions of the isolated 
heart was obtained in re5ponae to doses up to 800 mg. 
Smookler and DeFeo (1962) reported that 8 of the 10 
compounds tested on the isolated guinea pig hearts produced 
cardiac arres'to All the co:mpcnmds tested by Smith (1963) 
produced cardiac arresto Furthermore 9 all the compol.lll.ds 
tested by Koaega.rten (1966) produced mechanical arrest 9 
except trans~2-.Q.-tolyl=cis-4-hydroxy-trans-5-hydroxycyclo­
hexanolo Thu~ 9 our findings are in accord with those of 
previous investigatorso 
In this invastigation9 on the basi~ of the minimum 
calculated effective dose to produce cardiac arreat 9 it 
appears that methyl 3-hydroxy-2-.Q.-tolylcyclohexylacetate 
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(SH-21~.) and trans-3-oxo~2-.Q.~tolylcyclohexylacetic acid (SH-
16) were equally effective and the most potent (Table XI:). 
The ED 95 (cardio=inhibi.tory) of these compounds differed 
by Oo30 mg with the former exerting a slightly greater 
effecto However the duration of the arrest and the recovery 
time were more prolonged with SH-24 than with the other 
compound~ testedo It will be recalled from the blood pres-
sure studies, that these amne compounds were also equally 
potent in producing a hypOJtensive responseo The keta.l of' 
glycerol and 2-2-tolylcyclohexanone was the leaBt potent in 
its cardio=inhibitory effect~o From these findings it can 
be deduced that the presence of either a free hydroxy group 
or other substituent in the n'\!m1ber 3 position is necessary 
to elicit the desired pharmacological effecto This has been 
observed by previous workers in this fieldo The receptor 
site,therefore 9 muat possees ~ome area to fit with this sub-
stituent moietyo It could aJ.~o be said that the larger group 
at the 3 position9 the ketal of glycerol 9 must be producing 
a steric hindrance to the receptor sites, hence this com-
pound was the least active or tho~e te~tedo The longer 
duration of action of the methyl e~ter (SH-24) is obviously 
due to the blocking of the free ca.l"'boxylic acid grouping 
necessary f'or conjugation., 
In the3e experiment~ 9 in general 9 with regard to the 
duration of cardiac arre~t and to the per cent depression 
in the amplitude of contraction 9 a do~e-related response to 
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the compounds was foundo None of the compounds showed signs 
of cardiac toxicity, as indicated by the recove~y of the 
hearts from the effects of the compounds following either 
cardiac arrest or depresaiono 
Studies on the isolated rat atria showed that the 
compounds tested decreased the amplitude of contraction, 
except trans-3-oxo-2-.Q.-tolylcyclohexylacetic acid (SH-16) 
which produced a positive inotropic effecto Due to en in-
suf'ficient amount of this compound 9 only a 35 per cent increase 
in the amplitude of the atrial. contractions was recorded in 
response to loO mg of the compoundo The solvent employed 
for some of the compounds (polyethylene glycol) was found 
to cause a transient inotropic effect that lasted for 
approximately 60 seconds. Upon administration of the com-
pounds, this same effect occurred before and separate from 
the action of the compoundo Based on the calculated ED50, 
methyl 3-acetoxy-2-.Q.-tolylcyclohexylacetate (SH-26) was the 
most potent in decreasing the amplitude or the isolated 
atria. The ketal of glycerol and 2-.Q.-tolylcyclohexanone was 
second in comparative effectiveness, followed by 2-.Q.-tolyl-
cyclohexen-2-one. Methyl 3-hydroxy-2-.Q.- tolylcyclohexyl-
acetate (SH-24) was the least potento The mechanism of 
action of these compounds on the isolated atria is slightly 
different from that of compounds in previous tests. From 
the findings it can be said that there is a great need for 
the presence of a bulky substituent at the 3 position or 
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the cyclohexanol ring. It is better to say that the ..Q.-tolyl 
substituent should have a big group in an adjacent positiono 
Both methyl 3-acetoxy-2-Q.-tolylcyclohexylacetate and the 
ketal of glycerol and 2-..Q.~tolylcyclohexanone were the most 
potent. It is known that the bulky groups always try to 
occupy equatorial positions. The .Q.-tolyl and the acetoxy 
in the first compound and the ketal of glycerol on the 
second compound may be occupying an equatorial position to 
give the compound the best spatial configuration for its 
maximum action. 
It is of interest to mention that Smith (1963) re-
1 
ported that 2-.Q.-tolylcyclohexen-2-one produced a positive 
inotropic effect on the isolated atria in the dosage range 
tested. This is in contrast to the findings in this in-
vestigation. However, most of the doses employed by Smith 
were lower than those employed in this investigation. 
Studies with methyl 3-acetoxy-2-.Q.-tolylcyclohexyl-
acetate (SH-26) demonstrated that, following the depressant 
action of the compound on the isolated atria, the addition 
of calcium to the bath restored the amplitude of contrac-
. ~ 
tion of the atria to normal. These findings are similar to 
those reported by Smookler and DeFeo (1962). 
In order to determine the effect of the compounds on 
smooth muscle, isolated intestinal strips were utilized. 
The solvent employed for some of the compounds (polyethylene 
glycol) had a transient stimulating effect on the intestine. 
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Neither the tone nor the rate of contraction was a.f'fected 
by the solvent. In these experiments, all the compounds 
decreased the amplitude of contractions of the isolated 
intestine, except 3-hydroxy-2-.Q_-tolylcyclohexylacetic acid 
(SH-23), which caused an opposite effect in the dose range 
tested (Table XX). ?he effects on the rate were variable 
and inconsistent. All the compounds lowered the tone in 
varying degrees except methyl 3-hydroxy-2-.Q_-tolylcyclo-
hexylacetate (SH-24) which did not affect the tone (Table 
XVIII). 
The results in Tables XVIII to XXII show that the 
ketal of glycerol and 2-.Q_-tolylcyclohexanone was the most 
potent in depressing the amplitude of contractions and 
lowering the tone of the isolated rabbit ileum. 2-.Q.-Tolyl-
cyclohexen-2-one was the least potent. Thus, substitution 
at the number 1 position in the cyclohexanol ring does not 
favor the intestinal contraction. However, once again, a 
bulky group at the 3 position is best suited for depressing 
the amplitude of the isolated intestine. The receptor site 
may have either a cavity or a flat surface to accommodate 
this bulky group. 
Several experiments were carried out in an effort to 
determine the mechanism of action of these compounds on the 
smooth muscle tested. When acetylcholine was added to the 
bath after the depressant action of the ketal of glycerol 
and 2-.Q_-tolylcyclohexanone had occurred, it was found that 
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the subsequent response of acetylcholine was not diminished; 
therefore it appears that the compound is not acting at the 
terminal synapses of the parasympathetic nerves. 
In other experiments when barium chloride was added 
to the bath after the depressant action of the ketal of 
glycerol and 2-.Q.-tolylcyclohexanone, the response remained 
unchanged. 
V. SUMMARY AND OONCLUSIONS 
1. Several derivatives of 07olohexanol, recentl7 synthesized, 
were tested for v~ioua ph~acological actions. The 
tests were carried out on intact animals, isolated 
ca!'diac tissue, and rabbit small intestine. The•e 
compounds were found to aottvel7 a:f'fect the cardio-
vascular s7stem and the intestine smooth muscle. 
2. Due to the limited water solubility of some of the com-
pounds, onl7 two derivatives were tested on the blood 
pressure. The results indicate that these compounds 
produce a rapid hypotensive respon~e on the intact 
anesthetized rat. The magnitude of the effect varied 
with the dose administered. Both compound~, ~eth7l 
3-h7drox1-2-2-tolylo7clohex7laoetate and trans-3-oxo-
2-.Q.-tol7lc7clohex7laoetio acid., had approximatel7 equal 
poteno7. 
3. Experiments conducted on isolated guinea pig hearts 
indicate that decreased m1ooardial contractilit1 is 
responsible for the oa.rdioplegia produced b7 these 
compounds. Both meth7l 3-h7droxy-2-.Q.-tolfloyolo-
hex7lacetate ~d trans-3-oxo-2-Q.-tol7lc7clohex7lacetic 
acid exerted the greater cardio-inhibitor1 activity, 
and were equally effective, while the ketal of gl7cerol 
and 2-.Q.-tolylc7clohexan.one was the least active among 
the compouncls studied. None of the compounds appeared 
to be cardio-toxic. 
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4. In the isolated atrial studies~ the usual response was 
a decrease in the amplitude of contraction with no 
significant change in the rate of contraction. Trans-
3-oxo-2-.Q.-tolylcyclohexylacetic acid differed from the 
other compounds tested since it produced a positive 
inotropic effect on the atrial preparation. Methyl 
3-acetoxy-2~.Q.-tolylcyclohexylacetate was the most 
potent. Methyl .3-hydroxy-2-.Q.-tolylcyclohexylacetate 
possessed the least activity. 'l'll.e negative inotropic 
effect of methyl 3-acetox1-2-.Q.-tolylcyclohexylacetate 
was antagonized by calcium. 
5. All of the compounds were tested for their action on 
isolated intestinal muscle. All produced depression 
of the intestinal preparation, except 3-hydroxy-2-.Q.-
tolylcyclohexylacetic acid which caused an opposite 
effect. The ketal of glycerol and 2-.Q.-tolylcyclo-
hexanone was t~e most potent, while 2-.Q.-tolylcyclohexen-
2-one was the least active on the isolated intestine. 
Several experiments with the ketal of glycerol and 
2-.Q.-tolyloyclohexanone indicate that t~s compound 
does not antagoni~e the action of acet7lcholine. 
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